Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Corporation (ADMP) Stock Overview

Explore Adamis Pharmaceuticals Corporation’s financial performance, market position, analyst ratings, and future outlook.

ADMP●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.78
$0.007(0.85%)
U.S. Market is Open · 13:55

Adamis Pharmaceuticals Corporation (ADMP)

Meyka AI Score

Z

Key Financials

Market Cap7.3M
P/E Ratio-0.06
EPS (TTM)$-10.14
ROE-2.09%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

ADMP Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Adamis Pharmaceuticals Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ADMP on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Adamis Pharmaceuticals Corporation's NASDAQ-traded stock include a P/E ratio of -0.06 and a market capitalization of 7.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ADMP on the NASDAQ.

Price Performance (NASDAQ: ADMP)

1-Day Change
N/A
5-Day Change
19.03%
1-Month Change
-0.01%
3-Month Change
-63.95%
6-Month Change
-88.94%
Year-to-Date (YTD) Change
-93.30%
1-Year Change
-91.44%
3-Year Change
-98.67%
5-Year Change
-99.64%
All-Time (Max) Change
-100.00%

Contact Information

https://www.adamispharmaceuticals.com
858 997 2400
11682 El Camino Real, San Diego, CA, 92130

Company Facts

110 Employees
IPO DateAug 14, 1995
CountryUS

Frequently Asked Questions